Translate Functional Microbes into Nutritional & Therapeutic Products for Thriving Infants & Mothers 

The critical importance of seeding a healthy microbiome in infants to positively influence human development into childhood and beyond, is undisputed. However, investigations continue into the causal relationships between the gut microbiota and health outcomes in neonates, pre-term births, delivery mode (vaginal or C-section), lactation, post-weaning, the first 1000 days and into later life. 

That’s why each year, maternal-infant microbiome researchers from pharma, biotech, and academia, gather at the annual Microbiome Movement – Maternal & Infant Health Summit. Join this timely forum in March to grasp cutting-edge science and clinical data that validates functionally promising microbes as live biotherapeutic treatments and nutritional options for early life. 

With each session offering key take-homes, this is your best opportunity to clarify scientific challenges of elucidating causality between the maternal microbiome and pregnancy outcomes, and infant gut microbiome composition with long-term health outcomes, and translating these insights into the clinic.